| 000 | 01610 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515112936.0 | ||
| 264 | 0 | _c20080414 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a1744-8360 | ||
| 024 | 7 |
_a10.1586/14737175.8.3.479 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBenyamina, Amine | |
| 245 | 0 | 0 |
_aPharmacotherapy and psychotherapy in cannabis withdrawal and dependence. _h[electronic resource] |
| 260 |
_bExpert review of neurotherapeutics _cMar 2008 |
||
| 300 |
_a479-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aBehavior Therapy |
| 650 | 0 | 4 |
_aBuspirone _xtherapeutic use |
| 650 | 0 | 4 |
_aCannabinoids _xadverse effects |
| 650 | 0 | 4 | _aCognitive Behavioral Therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDronabinol _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMarijuana Abuse _xrehabilitation |
| 650 | 0 | 4 |
_aMianserin _xanalogs & derivatives |
| 650 | 0 | 4 | _aMirtazapine |
| 650 | 0 | 4 | _aMotivation |
| 650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
| 650 | 0 | 4 | _aPsychotherapy |
| 650 | 0 | 4 |
_aPsychotropic Drugs _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrazoles _xtherapeutic use |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRimonabant |
| 650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xrehabilitation |
| 700 | 1 | _aLecacheux, Marie | |
| 700 | 1 | _aBlecha, Lisa | |
| 700 | 1 | _aReynaud, Michel | |
| 700 | 1 | _aLukasiewcz, Michael | |
| 773 | 0 |
_tExpert review of neurotherapeutics _gvol. 8 _gno. 3 _gp. 479-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/14737175.8.3.479 _zAvailable from publisher's website |
| 999 |
_c17847333 _d17847333 |
||